Congratulations!

[Valid Atom 1.0] This is a valid Atom 1.0 feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

Source: http://www.pillole.org/public/aspnuke/feedatom10.asp

  1. <?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom" xml:lang="it"><title type="text">pillole.org</title><subtitle type="text">Pillole di medicina telematica info professionali mediche</subtitle><id>http://www.pillole.org/public/aspnuke/news.asp</id><link rel="alternate"   type="application/xhtml+xml" href="http://www.pillole.org/"/><link rel="self" type="application/atom+xml" href="http://www.pillole.org/public/aspnuke/feedatom10.asp"/><author><name>Pillole.org</name><uri>http://www.pillole.org</uri><email>info@pillole.org</email></author><rights>Copyright (c) 2005, Pillole.org</rights><updated>2024-04-26T00:00:00+01:00</updated><entry><title type="html">Brexpiprazolo nell'agitazione dell'Alzheimer</title><summary type="html">In uno studio randomizzato e controllato il brexpiprazolo ha dimostrato di ridurre l&#8217;agitazione nei pazienti con Alzheimer.
  2. </summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8425</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8425" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8425" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-26T06:28:00+01:00</updated></entry><entry><title type="html">Efficacia degli antidiabetici</title><summary type="html">Una revisione sistematica con metanalisi a rete ha valutato quali sono i benefici e i rischi dei vari farmaci antidiabetici.
  3. </summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8362</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8362" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8362" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-24T06:28:00+01:00</updated></entry><entry><title type="html">L&#8217;OPINIONE SU&#8230; Prestazioni delegate alla segretaria</title><summary type="html">[b][i]Posso delegare la mia segretaria per la compilazione di ricette al mio posto, per alleggerirmi il lavoro, quando io sono oberato dalle visite?[/b][/i]</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8395</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8395" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8395" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-24T00:24:00+01:00</updated></entry><entry><title type="html">La sindrome cardionefrometabolica</title><summary type="html">Un recente statement definisce una nuova entit&#224; nosologica: la sindrome cardionefrometabolica</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8418</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8418" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8418" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-21T08:00:00+01:00</updated></entry><entry><title type="html">Aggiornamento sullo scompenso cardiaco</title><summary type="html">L&#8217;ACC ha pubblicato un aggiornamento semplificato per la gestione dello scompenso cardiaco a frazione di eiezione ridotta.</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8390</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8390" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8390" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-21T06:28:00+01:00</updated></entry><entry><title type="html">Effetti della &#8220;cascata prescrittiva&#8221;</title><summary type="html">Uno studio osservazionale ha esaminati gli effetti di quella che gli autori definiscono &#8220;cascata prescrittiva&#8221;.</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8402</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8402" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8402" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-21T06:28:00+01:00</updated></entry><entry><title type="html">Novit&#224; in Gazzetta Ufficiale 13 - 19 aprile 2024</title><summary type="html">Provvedimenti di interesse medico-sanitario pubblicati in Gazzetta Ufficiale: 13 - 19 aprile 2024.</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8420</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8420" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8420" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-20T01:00:00+01:00</updated></entry><entry><title type="html">Proposti nuovi criteri per la diagnosi di diabete</title><summary type="html">Una nuova modalit&#224; di interpretazione della curva da carico permette di diagnosticare precocemente il diabete di tipo2 e il prediabete.
  4. </summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8387</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8387" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8387" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-19T06:28:00+01:00</updated></entry><entry><title type="html">Attenzione agli integratori, soprattutto se non sono ben conosciuti!</title><summary type="html">Spesso si assumono integratori con troppa leggerezza, considerandoli prodotti innocui, che fanno bene alla salute. Cosi&#8217; spesso vengono scelti e assunti in completa autonomia.</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8414</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8414" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8414" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-17T00:21:00+01:00</updated></entry><entry><title type="html">Malattia da reflusso GE non erosiva e cancro esofageo</title><summary type="html">Uno studio eseguito in alcuni paesi del nord Europa suggerisce che il rischio di adenocarcinoma esofageo nei pazienti con malattia da reflusso gastro-esofageo non erosiva &#232; simile a quello della popolazione generale.
  5. </summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,:?id=8348</id><link href ="http://www.pillole.org/public/aspnuke/news.asp?id=8348" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8348" type="application/xhtml+xml" hreflang="it" /><updated>2024-04-16T06:28:00+01:00</updated></entry></feed>

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

  1. Download the "valid Atom 1.0" banner.

  2. Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)

  3. Add this HTML to your page (change the image src attribute if necessary):

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=http%3A//www.pillole.org/public/aspnuke/feedatom10.asp

Copyright © 2002-9 Sam Ruby, Mark Pilgrim, Joseph Walton, and Phil Ringnalda